Houlihan Lokey Q2 Shows Slowing Growth and Flat EPS, Reinforcing Bearish Stance

What happened

Houlihan Lokey reported Q2 FY27 revenue of $692 million, up 5% year-over-year, but adjusted EPS remained flat at $1.85, signaling that modest top-line growth was offset by higher costs or margin compression. Management described the environment as "normalizing" and cautioned about macroeconomic volatility, geopolitical instability, and continued software sector dislocation, all of which are headwinds for mid-market M&A and restructuring activity. These results undercut the bullish narrative that HLI could sustain low-to-mid-teens EPS growth, as the company's own guidance and actuals point to a more muted trajectory. The DeepValue master report had already flagged HLI as a potential sell at $164 with a bear case targeting $145, noting weak mid-market activity and rising fixed costs; the Q2 data appears to validate that concern. With revenue growth decelerating from prior double-digit rates and EPS stagnant, the risk of multiple compression from current premium levels (~24x trailing EPS) increases, making a pullback toward the attractive entry zone more likely.

Implication

The Q2 results reinforce the bearish thesis that HLI's growth is normalizing faster than the market expected, which may lead to de-rating. Given the flat EPS and cautious outlook, the base case of ~10% EPS growth and stable margins appears optimistic; there is a higher probability of margin compression toward 21-22% as fixed costs rise. The stock's premium valuation (~24x trailing EPS) leaves little room for error; if mid-market M&A remains sluggish, downside to $145 (12% below the report's price) is plausible. Investors should monitor upcoming quarters for signs of revenue acceleration or margin stabilization; without clear evidence, staying underweight or in cash equivalents until a better entry point is prudent. The European build-out and cost control are key swing factors; if these fail to deliver productivity, the bear case becomes more probable.

Thesis delta

The Q2 FY27 results with only 5% revenue growth and flat EPS directly contradict the bull case of sustained double-digit growth, tilting the thesis further toward bearish. The master report's potential sell rating and bear scenario ($145) are now more credible, as the 'normalizing' environment and caution signal potential margin erosion. Consequently, the investment stance shifts from neutral to more defensive, with reduced conviction in any near-term upside above $190.